Advances in antitumor effects of NSAIDs

In recent years, the reports on using nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer prevention and treatment have been on the rise. In 2017, the US Preventive Services Working Group issued primary prevention guidelines on the use of NSAIDs, especially aspirin, for cardiovascular disease a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhen, Chen, Fulin, Shang, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197827/
https://www.ncbi.nlm.nih.gov/pubmed/30410398
http://dx.doi.org/10.2147/CMAR.S175212
_version_ 1783364848248160256
author Zhang, Zhen
Chen, Fulin
Shang, Lijun
author_facet Zhang, Zhen
Chen, Fulin
Shang, Lijun
author_sort Zhang, Zhen
collection PubMed
description In recent years, the reports on using nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer prevention and treatment have been on the rise. In 2017, the US Preventive Services Working Group issued primary prevention guidelines on the use of NSAIDs, especially aspirin, for cardiovascular disease and colorectal cancer, and formally established the role and status of aspirin in cancer prevention. However, the mechanism of NSAIDs on preventing cancer is still not clear. In this paper, the progress of the application of NSAIDs, especially aspirin, in the prevention and treatment of tumors in recent years is summarized, and new ideas and directions for the follow-up study are also discussed.
format Online
Article
Text
id pubmed-6197827
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61978272018-11-08 Advances in antitumor effects of NSAIDs Zhang, Zhen Chen, Fulin Shang, Lijun Cancer Manag Res Review In recent years, the reports on using nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer prevention and treatment have been on the rise. In 2017, the US Preventive Services Working Group issued primary prevention guidelines on the use of NSAIDs, especially aspirin, for cardiovascular disease and colorectal cancer, and formally established the role and status of aspirin in cancer prevention. However, the mechanism of NSAIDs on preventing cancer is still not clear. In this paper, the progress of the application of NSAIDs, especially aspirin, in the prevention and treatment of tumors in recent years is summarized, and new ideas and directions for the follow-up study are also discussed. Dove Medical Press 2018-10-15 /pmc/articles/PMC6197827/ /pubmed/30410398 http://dx.doi.org/10.2147/CMAR.S175212 Text en © 2018 Zhang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Zhang, Zhen
Chen, Fulin
Shang, Lijun
Advances in antitumor effects of NSAIDs
title Advances in antitumor effects of NSAIDs
title_full Advances in antitumor effects of NSAIDs
title_fullStr Advances in antitumor effects of NSAIDs
title_full_unstemmed Advances in antitumor effects of NSAIDs
title_short Advances in antitumor effects of NSAIDs
title_sort advances in antitumor effects of nsaids
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197827/
https://www.ncbi.nlm.nih.gov/pubmed/30410398
http://dx.doi.org/10.2147/CMAR.S175212
work_keys_str_mv AT zhangzhen advancesinantitumoreffectsofnsaids
AT chenfulin advancesinantitumoreffectsofnsaids
AT shanglijun advancesinantitumoreffectsofnsaids

Ejemplares similares